Most gastrointestinal side effects are classified as mild to moderate in severity and tend to occur primarily during dose escalation periods
J Endocrinol Invest 19 : 114118, 1996
The FDA labeling documents gastrointestinal adverse effects broadlyincluding nausea (occurring in 1544% of patients depending on dose and indication), vomiting, diarrhea, abdominal pain, and constipation
Pain typically develops only after a bone breaks, especially with compression fractures in the spine, which can cause sudden back pain, height loss, and a stooped posture
That leads to a more confident mindset, better results, and a healthier lifestyle overall
(Lausanne) 9, 953749